Search clinical trials for: Motor abilities

Total 6895 results

National University Hospital, Singapore

Completed

Study Using Esomeprazole as a Diagnostic Test for GERD in Patients With NCCP (ECP)

Gastroesophageal Reflux Disease

Singapore
University of Alberta
ALS Association

Completed

The Effect of Memantine on Functional Outcomes and Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

Canada
The Oregon Clinic

Unknown

Endolumenal Partial Myotomy for the Treatment of Esophageal Achalasia

Achalasia

United States
The Oregon Clinic

Unknown

Endolumenal Partial Myotomy for Esophageal Motility Disorders

Esophageal Motility Disorders

United States
Rhode Island Hospital

Unknown

Reducing Driving Offenses of Adolescent Drinkers (ROAD)

Alcohol Consumption

United States
University of Cincinnati

Completed

Mental Practice Impact on Gait and Cortical Organization in Spinal Cord Injury (SCI)

Incomplete Spinal Cord Injury
University College, London
Medical Research Council

Completed

Dopamine Agonist for Hemispatial Neglect and Motor Deficit Post Stroke

Hemispatial Neglect | Motor Deficit | Right Hemisphere Stroke

United Kingdom
University of Iowa
Blank Children's Hospital

Completed

Parent-based Intervention to Increase Safe Teen Driving

Motor Vehicle Occupant Injury | Teenaged Driver

United States
Novartis

Terminated

Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off

Parkinson's Disease

United States
AstraZeneca
i3 Innovus

Completed

Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient - a Study in France (REMAIN)

Gastroesophageal Reflux Disease

France
University of Genova

Unknown

Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot-Marie-Tooth Neuropathy Type 1A (CMT1A) (TreSPE)

Charcot-Marie-Tooth Disease | Charcot-Marie-Tooth Disease Type 1A

Italy
Columbia University
Pfizer; ALS Association

Completed

Combination Therapy Selection Trial in Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

United States
Newron Pharmaceuticals SPA

Completed

18-month Study of Long-term Efficacy & Safety of Safinamide as add-on Therapy in Patients With Mid-late Stage PD

Parkinson's Disease
University of Lausanne Hospitals
University of Zurich; University of Lausanne; University of Basel

Completed

Effect of a Physical-activity-promoting Environment on Motor Skills, Physical Activity and Quality of Life of Children in Childcare Settings (Youp'là bouge)

Obesity | Inactivity

Switzerland
National Institute of Neurological Disorders and...

Completed

Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA)

Spinal and Bulbar Muscular Atrophy | Kennedy's Disease

United States
AstraZeneca

Completed

Open, Randomized, Two Way Crossover 40mg, Orally and Intravenously

GERD
AstraZeneca

Completed

An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)

GERD
AstraZeneca

Completed

Chronic Posterior Laryngitis With Suspected Laryngopharyngeal Reflux

Chronic Posterior Laryngitis (CPL)
AstraZeneca
Mitsubishi Tanabe Pharma Corporation

Completed

A Study to Investigate the Pharmacodynamic Effect After Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population

Non-erosive Reflux Disease

Japan
Stentys

Completed

STENTYS Self-expanding Versus Balloon-expandable Stent in Acute Myocardial Infarction (AMI) (APPOSITION ll)

STEMI

France
AstraZeneca

Completed

Chest Pain Pilot Study

Chest Pain | Gastroesophageal Reflux

Sweden, Germany, Denmark, Norway, Canada, Netherlands
AstraZeneca
Mitsubishi Tanabe Pharma Corporation

Completed

Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population

Non-erosive Reflux Disease

Japan
AstraZeneca

Completed

Symptom Adapted Therapy in GERD Patients (SYMPATHY)

Gastroesophageal Reflux Disease

Germany
AstraZeneca

Completed

Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease
AstraZeneca

Completed

Open, Randomized, Two Way Crossover Study Comparing the Effect of Esomeprazole Adminstered Orally and iv

Gastroesophageal Reflux Disease
Johnson & Johnson Pharmaceutical Research & Development...

Terminated

A Study of Cisapride in Patients With Symptomatic Gastro-Oesophageal Reflux Disease

Gastroesophageal Reflux
AstraZeneca

Completed

Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease | Heartburn
University Hospital, Clermont-Ferrand
University Hospital, Limoges; Institut National de Recherche pour l'Agriculture...

Unknown

Mitochondrial Functions and Oxidative Stress in ALS Patients

Amyotrophic Lateral Sclerosis

France
University Hospital, Clermont-Ferrand
Centre Hospitalier Universitaire de Saint Etienne; Centre Hospitalier Universitaire... and other collaborators

Unknown

HEMITOX : Effect of Botulinum Toxin Injections on Motor and Functional Ability of Upper Limb in Adults at Earlier Phases of Spastic Hemiplegia After Stroke

Hemiplegia

France
Universita di Verona

Completed

Spread And Effectiveness Of Botulinum Neurotoxin A In Spastic Equinus In Cerebral Palsy

Cerebral Palsy and Botulinum Toxin
University of Arkansas

Completed

Palliative Strategies in Spinal Cord Injury (SCI)

Spinal Cord Injury

United States
AstraZeneca

Completed

Non-interventional Study to Evaluate the Change in Symptoms Scores and Treatment Response After 4 Weeks of Proton-Pump Inhibitors (PPI) Treatment

Gastroesophageal Reflux

Romania
Johnson & Johnson Pharmaceutical Research & Development...
Eisai Inc.

Completed

A Pharmacokinetic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Years Old, Inclusive

GERD
Tampere University
Kamuzu University of Health Sciences; University of Glasgow; Singapore Clinical...

Completed

Validating Accelerometers to Study Physical Activity of Toddlers

Motor Activity

Malawi
AstraZeneca

Completed

Efficacy and Safety of Esomeprazole Once Daily for the Treatment of GERD in Neonatal Patients

GERD

Germany, United Kingdom, Australia
AstraZeneca

Completed

Reflux Esophagitis Phase III Study (Initial Treatment)

Reflux Esophagitis

Japan
Cirujanos la Serena

Completed

Pancreaticobiliary Reflux in Patients Without Cholelithiasis

Pancreaticobiliary Reflux

Chile
Nantes University Hospital

Terminated

Elaboration of a Pre-surgery Mapping Protocol of Primary Motor Cortex, Prior to an Implementation of a Stimulation of Primary Motor Cortex for Patients With Deafferentiation of Brachial Plexus Pain (CCPB)

Painful Avulsion of Brachial Plexus

France
National Taiwan University Hospital

Unknown

Symptom Assessment for GERD Patients Receiving H. Pylori Eradication

Gastroesophageal Reflux Disease

Taiwan
National Taiwan University Hospital

Unknown

Explore the Nature Factors Relevant to Learning-Pioneering Natural Factors That Influences Science Learning II

Healthy

Taiwan
Medical University of Vienna

Unknown

Paclitaxel Balloon Versus Standard Balloon in In-stent Restenoses of the Superficial Femoral Artery (PACUBA I Trial) (PACUBA 1)

Peripheral Arterial Disease

Austria
AstraZeneca

Completed

AZD3355 Dose-escalation Study in Healthy Males

Reflux Disease

Sweden
AstraZeneca

Completed

The Clinical Significance of Minimal Change in Reflux Esophagitis Based on the Gastroesophageal Reflux Disease Questionnaire (MIGHT)

Gastroesophageal Reflux Disease

Korea, Republic of
AstraZeneca

Completed

Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients (Preedom)

Gastroesophageal Reflux Disease

Korea, Republic of
AstraZeneca

Completed

Symptoms and Management Strategies in Gastroesophageal Reflux Disease (GERD) (PHENIX)

Gastroesophageal Reflux Disease

Croatia
AstraZeneca

Completed

Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment.

Gastroesophageal Reflux Disease

Vietnam
Uniformed Services University of the Health Sciences

Unknown

Research Abstract Usefulness in Clinical Decision-making

Clinical Decision-making

United States
AstraZeneca

Completed

Structured Treatment of Gastroesophageal Reflux in a Company Health Care Setting, -Effect on Quality of Life, Symptoms and Productivity

GERD

Sweden
AstraZeneca

Completed

Gastroesophageal Reflux Disease (GERD) Segmentation: Document How Swiss General Practitioners (GPs) Allocate Their GERD Patients to the Three GERD Patient Segments

GERD

Switzerland
AstraZeneca

Completed

Drug Interaction Study Between AZD3355 and Nexium

Gastroesophageal Reflux Disease

Sweden

3

Subscribe